Abstract
Varicella zoster (VZ) virus was first isolated in tissue culture by Weller (1953), about 30 years ago. As Krugman (1984) has pointed out, vaccines against polio, measles, and rubella became licensed at the most within 16 years after it was possible to propagate the respective agents in the laboratory. The hepatitis B virus vaccine was developed even before that agent could be propagated. It might therefore seem surprising that there is, after 30 years, no vaccine licensed for prevention of disease caused by VZ virus. Fortunately, however, despite this long lag period a vaccine has been developed and it is being tested. This vaccine will probably become commercially available within the next few years.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arbeter AM, Starr SE, Weibel RE, et al. (1982) Live attenuated varicella vaccine: immunization of healthy children with the OKA strain. J Pediatr 100:886–893
Bokay J (1909) Über den ätiologischen Zusammenhang der Varizellen mit gewissen Fällen von Herpes zoster. Wein Klin Wochenschr 22:1323–1326
Brunell P (1977) Brunell’s brush-off. Pediatrics 59:954
Brunell PA, Geiser C, Shehab Z, et al. (1982) Administration of live varicella vaccine to children with leukemia. Lancet 2:1069–1072
Cheatham WJ, Weller TH, Dolan TF, et al. (1956) Varicella: report of two fatal cases with necropsy, virus, isolation, and serologic studies. Am J Pathol 32:1015–1028
Feldman S, Hughes WT, Daniel CB (1975) Varicella in children with cancer. Pediatrics 56:388–397
Garland J (1943) Varicella following exposure to herpes zoster. N Engl J Med 228:336–337
Gershon AA (1980) Live attenuated varicella-zoster vaccine. Rev Infect Dis 2:393–407
Gershon AA, Steinberg S, Gelb L (1984) The National Institute of Allergy and Infectious Diseases Collaborative Varicella Vaccine Study Group. Efficacy of varicella vaccine in children with leukemia in remission. JAMA 252:355–362
Izawa T, Ihara T, Hattori A, et al. (1977) Application of a live varicella vaccine in children with acute leukemia or other malignant diseases. Pediatrics 60:805–809
Krugman S (1984) Evaluation of hepatitis B vaccine. Presented at 4th international Symposium on rapid methods and automation in microbiology and immunology, Berlin
Martin JH, Dohner DE, Wellinghof WJ, et al. (1982) Restriction endonuclease analysis of varicellazoster vaccine virus and wild-type DNAs. J Med Virol 9:69–76
Plotkin S (1977) Varicella vendetta: Plotkin’s plug. Pediatrics 59:953–954
Ross AH, Lenchner E, Reitman G (1962) Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 267:369–376
Sakurai M, Ihara T, Ito M, et al. (1982) Application of a live varicella vaccine in children with acute leukemia. In: Herpes virus: clinical pharmacological and basic aspects. Shiota, Cheng, Prusoff (eds) Exerpta Medica, Amsterdam, pp 87–93
Straus SE, Hay J, Smith H, et al. (1983) Genome differences among varicella-zoster virus isolates. J Gen Virol 64:1031–1041
Takahashi M (1983) Chickenpox virus. Adv Virus Res 28:285–356
Takahashi M, Otsuka T, Okuno Y, et al. (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288–1290
Weibel R, Kuter B, McLean A, et al. (1984) Efficacy of varicella vaccine in normal children. N Engl J Med (to be published)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gershon, A. (1985). Development of a Live Attenuated Vaccine Against Varicella. In: Habermehl, KO. (eds) Rapid Methods and Automation in Microbiology and Immunology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69943-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-69943-6_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69945-0
Online ISBN: 978-3-642-69943-6
eBook Packages: Springer Book Archive